Autori: Damstrup Lars
| Naslov | Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer. (Meeting Abstract) |
| Autori | Van Cutsem Eric Hidalgo Manuel Bazin Igor Canon Jean-Luc Poddubskaya Elena Manojlovic Nebojsa S  Milella Michele Radenkovic Dejan V Verslype Chris Guo Wei Damstrup Lars Hammel Pascal
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2015), vol. 33 br. 3, Suppl. S, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
     |
